Literature DB >> 22569962

Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity.

Ariela Benigni1, Silvia Orisio, Marina Noris, Paraskevas Iatropoulos, Davide Castaldi, Kei Kamide, Hiromi Rakugi, Yasumichi Arai, Marta Todeschini, Giulia Ogliari, Enyu Imai, Yasuyuki Gondo, Nobuyoshi Hirose, Daniela Mari, Giuseppe Remuzzi.   

Abstract

Longevity phenotype in humans results from the influence of environmental and genetic factors. Few gene polymorphisms have been identified so far with a modest effect on lifespan leaving room for the search of other players in the longevity game. It has been recently demonstrated that targeted disruption of the mouse homolog of the human angiotensin II type 1 receptor (AT1R) gene (AGTR1) translates into marked prolongation of animal lifespan (Benigni et al., J Clin Invest 119(3):524-530, 2009). Based on the above study in mice, here we sought to search for AGTR1 variations associated to reduced AT1 receptor protein levels and to prolonged lifespan in humans. AGTR1 was sequenced in 173 Italian centenarians and 376 younger controls. A novel non-synonymous mutation was detected in a centenarian. Two polymorphisms in AGTR1 promoter, rs422858 and rs275653, in complete linkage disequilibrium, were significantly associated with the ability to attain extreme old age. We then replicated the study of rs275653 in a large independent cohort of Japanese origin (598 centenarians and semi-supercentenarians, 422 younger controls) and indeed confirmed its association with exceptional old age. In combined analyses, rs275653 was associated to extreme longevity either at recessive model (P = 0.007, odds ratio (OR) 3.57) or at genotype level (P = 0.015). Significance was maintained after correcting for confounding factors. Fluorescence activated cell sorting analysis revealed that subjects homozygous for the minor allele of rs275653 had less AT1R-positive peripheral blood polymorphonuclear cells. Moreover, rs275653 was associated to lower blood pressure in centenarians. These findings highlight the role of AGTR1 as a possible candidate among longevity-enabling genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569962      PMCID: PMC3636412          DOI: 10.1007/s11357-012-9408-8

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  36 in total

1.  Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus.

Authors:  Toshihiko Inukai; Noboru Yoshida; Sadao Wakabayashi; Yoshihisa Inukai; Rika Matsutomo; Keishi Takanashi; Takashi Nakamachi; Kohzo Takebayashi; Yoshimasa Aso; Kiyoko Takahashi
Journal:  Am J Med Sci       Date:  2005-05       Impact factor: 2.378

2.  FOXO3A genotype is strongly associated with human longevity.

Authors:  Bradley J Willcox; Timothy A Donlon; Qimei He; Randi Chen; John S Grove; Katsuhiko Yano; Kamal H Masaki; D Craig Willcox; Beatriz Rodriguez; J David Curb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

Review 3.  The structure and function of G-protein-coupled receptors.

Authors:  Daniel M Rosenbaum; Søren G F Rasmussen; Brian K Kobilka
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

4.  Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils.

Authors:  Gonzalo Alba; Rajaa El Bekay; Pedro Chacón; M Edith Reyes; Eladio Ramos; Josefina Oliván; Juan Jiménez; José M López; José Martín-Nieto; Elízabeth Pintado; Francisco Sobrino
Journal:  J Leukoc Biol       Date:  2008-05-30       Impact factor: 4.962

Review 5.  Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review.

Authors:  Amy K Mottl; David A Shoham; Kari E North
Journal:  Genet Med       Date:  2008-08       Impact factor: 8.822

6.  Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up.

Authors:  Luigina Guasti; Franca Marino; Marco Cosentino; Ramona C Maio; Emanuela Rasini; Marco Ferrari; Luana Castiglioni; Catherine Klersy; Giovanni Gaudio; Anna M Grandi; Sergio Lecchini; Achille Venco
Journal:  Eur Heart J       Date:  2008-04-03       Impact factor: 29.983

7.  Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome.

Authors:  Paolo Palatini; Giulio Ceolotto; Francesca Dorigatti; Lucio Mos; Massimo Santonastaso; Paolo Bratti; Italia Papparella; Achille C Pessina; Andrea Semplicini
Journal:  Am J Hypertens       Date:  2008-11-20       Impact factor: 2.689

Review 8.  Signaling mechanisms of angiotensin II in regulating vascular senescence.

Authors:  Li-Juan Min; Masaki Mogi; Masaru Iwai; Masatsugu Horiuchi
Journal:  Ageing Res Rev       Date:  2008-12-31       Impact factor: 10.895

9.  Disruption of the Ang II type 1 receptor promotes longevity in mice.

Authors:  Ariela Benigni; Daniela Corna; Carla Zoja; Aurelio Sonzogni; Roberto Latini; Monica Salio; Sara Conti; Daniela Rottoli; Lorena Longaretti; Paola Cassis; Marina Morigi; Thomas M Coffman; Giuseppe Remuzzi
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

10.  Association of FOXO3A variation with human longevity confirmed in German centenarians.

Authors:  Friederike Flachsbart; Amke Caliebe; Rabea Kleindorp; Hélène Blanché; Huberta von Eller-Eberstein; Susanna Nikolaus; Stefan Schreiber; Almut Nebel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

View more
  20 in total

Review 1.  Genetic and epigenetic regulation of human aging and longevity.

Authors:  Brian J Morris; Bradley J Willcox; Timothy A Donlon
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-01       Impact factor: 5.187

2.  Angiotensin II- and Alzheimer-Type Cardiovascular Aging.

Authors:  Hannah A Cooper; Rosario Scalia; Victor Rizzo; Satoru Eguchi
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

3.  Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.

Authors:  Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Jose L Lanciego; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Age (Dordr)       Date:  2012-09-18

4.  Angiotensin Converting Enzyme (ACE) Inhibitor Extends Caenorhabditis elegans Life Span.

Authors:  Sandeep Kumar; Nicholas Dietrich; Kerry Kornfeld
Journal:  PLoS Genet       Date:  2016-02-26       Impact factor: 5.917

5.  Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.

Authors:  Ana I Rodriguez-Perez; Ana Borrajo; Carmen Diaz-Ruiz; Pablo Garrido-Gil; Jose L Labandeira-Garcia
Journal:  Oncotarget       Date:  2016-05-24

6.  Strategies and Challenges in Clinical Trials Targeting Human Aging.

Authors:  John C Newman; Sofiya Milman; Shahrukh K Hashmi; Steve N Austad; James L Kirkland; Jeffrey B Halter; Nir Barzilai
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-08-16       Impact factor: 6.053

7.  Association of Genetic Polymorphisms of Renin-Angiotensin-Aldosterone System-Related Genes with Arterio-Venous Fistula Malfunction in Hemodialysis Patients.

Authors:  Yu-Wei Chen; Yu-Te Wu; Jhin-Shyaun Lin; Wu-Chang Yang; Yung-Ho Hsu; Kuo-Hua Lee; Shou-Ming Ou; Yung-Tai Chen; Chia-Jen Shih; Pui-Ching Lee; Chia-Hao Chan; Ming-Yi Chung; Chih-Ching Lin
Journal:  Int J Mol Sci       Date:  2016-05-27       Impact factor: 5.923

Review 8.  Insulin-Like Growth Factor-1 and Neuroinflammation.

Authors:  Jose L Labandeira-Garcia; Maria A Costa-Besada; Carmen M Labandeira; Begoña Villar-Cheda; Ana I Rodríguez-Perez
Journal:  Front Aging Neurosci       Date:  2017-11-03       Impact factor: 5.750

Review 9.  From rapalogs to anti-aging formula.

Authors:  Mikhail V Blagosklonny
Journal:  Oncotarget       Date:  2017-05-30

10.  Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration.

Authors:  Carmen Diaz-Ruiz; Ana I Rodriguez-Perez; Daniel Beiroa; Jannette Rodriguez-Pallares; Jose L Labandeira-Garcia
Journal:  Oncotarget       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.